[go: up one dir, main page]

ES2058161T3 - Producto activo para la lucha contra tumores. - Google Patents

Producto activo para la lucha contra tumores.

Info

Publication number
ES2058161T3
ES2058161T3 ES88104603T ES88104603T ES2058161T3 ES 2058161 T3 ES2058161 T3 ES 2058161T3 ES 88104603 T ES88104603 T ES 88104603T ES 88104603 T ES88104603 T ES 88104603T ES 2058161 T3 ES2058161 T3 ES 2058161T3
Authority
ES
Spain
Prior art keywords
active product
fight against
against tumors
tumors
fight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88104603T
Other languages
English (en)
Inventor
Stephen Dr Merry
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF SE
Original Assignee
BASF SE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BASF SE filed Critical BASF SE
Application granted granted Critical
Publication of ES2058161T3 publication Critical patent/ES2058161T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

SE DESCRIBE LA UTILIZACION DE "NORVERAPAMIL" SOLA O EN COMBINACION CON CANCEROSTATICOS, EN LA TERAPIA DE TUMORES.
ES88104603T 1987-03-31 1988-03-23 Producto activo para la lucha contra tumores. Expired - Lifetime ES2058161T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873710806 DE3710806A1 (de) 1987-03-31 1987-03-31 Wirkstoff zur tumorbekaempfung

Publications (1)

Publication Number Publication Date
ES2058161T3 true ES2058161T3 (es) 1994-11-01

Family

ID=6324536

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88104603T Expired - Lifetime ES2058161T3 (es) 1987-03-31 1988-03-23 Producto activo para la lucha contra tumores.

Country Status (6)

Country Link
US (1) US4935445A (es)
EP (1) EP0285906B1 (es)
JP (1) JPS63258414A (es)
AT (1) ATE92758T1 (es)
DE (2) DE3710806A1 (es)
ES (1) ES2058161T3 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3826796A1 (de) * 1988-08-06 1990-02-08 Basf Ag Substituierte phenylacetonitrile zur verwendung als resistenzbrecher
DE3921006A1 (de) * 1989-06-27 1991-01-03 Knoll Ag Verwendung von nor-verapamil und nor-gallopamil als antiarteriosklerotica
US20090149453A1 (en) * 2002-05-23 2009-06-11 Activbiotics Pharma Llc Methods and compositions for treating bacterial infections and diseases associated therewith
US20040077533A1 (en) * 2002-05-23 2004-04-22 Sayada Chalom B. Methods and compositions for treating bacterial infections and diseases associated therewith
AU2003265241A1 (en) * 2002-05-23 2003-12-12 Activbiotics, Inc. Methods of treating bacterial infections and diseases associated therewith
US7423008B2 (en) * 2004-03-01 2008-09-09 University Of Kentucky Research Foundation Derivatives of mithramycin and methods of making and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3138488A1 (de) * 1981-09-28 1983-04-14 Knoll Ag, 6700 Ludwigshafen Verwendung von basisch substituierten phenylacetonritrilen bei der vorbeugenden bekaempfung von krankheiten und mittel dafuer
JPH0753665B2 (ja) * 1984-04-20 1995-06-07 財団法人癌研究会 抗転移剤
DE3635930A1 (de) * 1986-10-22 1988-04-28 Basf Ag Wirkstoffe zur anwendung bei der behandlung von tumoren

Also Published As

Publication number Publication date
DE3883044D1 (de) 1993-09-16
JPS63258414A (ja) 1988-10-25
EP0285906A2 (de) 1988-10-12
US4935445A (en) 1990-06-19
ATE92758T1 (de) 1993-08-15
EP0285906B1 (de) 1993-08-11
EP0285906A3 (en) 1990-02-07
DE3710806A1 (de) 1988-10-27

Similar Documents

Publication Publication Date Title
CY1105818T1 (el) Χρησεις του et743 στην θepαπευτικη αγωγη του καρκινου
BR9715022A (pt) Método para tratar de doenças prostáticas usando formulações de vitamina d por liberação sistemática e/ou prolongada
MX9504415A (es) Eteres antivirales de isoesteres de sustrato de proteasa de aspartato.
FI19991893A (fi) Säädellysti budesonidia vapauttava oraalisesti annettava koostumus ja budesonidin käyttö
EP0211354A3 (en) Nucleosides and their use as antineoplastic agents
BR0115162A (pt) Tratamentos antitumorais eficazes
PT933995E (pt) Metodo para tratamento de lesao endotelial
RU94022017A (ru) Способ лечения акне или псевдофолликулита бороды, способ получения композиции, применение ингибитора фермента орнитиндекарбоксилазы для лечения акне или псевдофолликулита бороды
IE40860B1 (en) Substituted benzamides
IL138290A0 (en) Use of selegiline or desmethylselegiline for treating wounds, burns and dermatological damage
PT1001775E (pt) Medicamento contendo ioimbina e arginina para tratamento de disfuncao erectil
ES2058161T3 (es) Producto activo para la lucha contra tumores.
MX9203405A (es) Compuestos activos para usarse en el tratamiento de tumores.
SE8102161L (sv) "3,7,11,15-tetrametyl-2,4,6,10,14-hexadekapentaensyra
DE3462688D1 (en) 1,7-diphenyl-3-methylaza-7-cyano-8-methylnonane useful in combating diseases
AU2525488A (en) Use of metalloporphyrins to reverse the toxic effect of tumor therapy
KR930702016A (ko) 골다공증 치료제
IT8622631A0 (it) Mono, di e tri-esteri del diidrossi 1,8 fenil 10 antrone 9 oppure antranolo-9 loro procedimento di preparazione e loro impiego in medicina umana o veterinaria e in cosmetica.
BR9007080A (pt) Aplicacao de derivados de 1,2-benzopirona para o tratamento de tumores malignos no homem
ES2054097T3 (es) Agente para el tratamiento de enfermedades inflamatorias cronicas del intestino.
PH24028A (en) The use of anipamil in the treatment of arteriosclerosis
SE9404405D0 (sv) Anordning för strålbegränsning
ES489956A0 (es) Sistema para la aplicacion de tratamientos bronceadores y terapeuticos integrales del cuerpo humano
MX9203715A (es) Preparciones para el tratamiento del tejido aloinjertado.
AR223681A1 (es) Procedimiento para la obtencion de complejos de platino-diamina utilizados como agente activo en el tratamiento del cancer

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 285906

Country of ref document: ES